Operative hysteroscopy in a hospital setting has revolutionized surgical treatment of benign uterine disorders. It is minimally invasive, cost-and timeeffective, and may spare patients major surgical interventions. Operative hysteroscopy in a day-case hospital setting is regarded as a safe and welltolerated procedure with low complication rates. However, prevention of adverse events is crucial in daily practice to optimize patient care. Complications in operative hysteroscopy can be divided into early complications, including bleeding, uterine perforation, infection and fluid overload, or late complications and suboptimal outcomes, such as incomplete resection and intrauterine adhesions. Awareness and knowledge of management of adverse events as well as the use of possible preventative measures will increase the quality and safety of hysteroscopic surgery. The present commentary focuses on these issues as an up-to-date basis for everyday clinical practice.
Introduction
The aim of hysteroscopic surgery is visualization and treatment of benign changes of the uterine cavity. It is minimally invasive with a short learning curve and is regarded as safe, efficient, well-tolerated and cost-effective, with increasing availability and use in gynecological surgery. Operative hysteroscopy (OH) plays a pivotal role in surgical management of subfertility and recurrent pregnancy loss aiming to optimize and restore cavitary anatomy. Several pathologies contributing to infertility can be corrected with OH, including cervical and uterine polyps, adhesions, uterine septa, blocked tubal ostia and submucosal myomas. OH also provides diagnostic workup for abnormal uterine bleeding, treatment of heavy menstrual bleeding, removal of foreign bodies and sterilization.
Complications in OH can be divided into early complications, such as bleeding, uterine perforation, infection and fluid overload, or late complications and suboptimal
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Operative hysteroscopy is safe and minimally invasive for treatment of benign uterine disorders. Knowledge and prevention of early and late adverse events are crucial for the safety and quality of hysteroscopic surgery. Preventative measures should be recognized and undertaken. outcomes, such as incomplete resection and intrauterine adhesions. Two large national studies including 24 191 OHs found a complication rate of <1% (1,2), whereas a retrospective study of 925 hysteroscopies observed a complication rate of 2.7% (3). A prospective study of 2515 OHs found that the strongest predictor of complications was the type of procedure performed, adhesiolysis carrying the highest risk of complications (4.5%), followed by endometrial resection (0.8%), myomectomy (0.8%) and polypectomy (0.4%) (2) . Hence, awareness of the most common complications and preventative measures to avoid adverse events are key to high-quality patient care.
Early complications
Bleeding and uterine perforation Bleeding may occur during or after OH as a result of mechanical trauma to the endometrium and/or myometrial vessels. Uterine perforation may cause severe bleeding, with injury of uterine arteries or even pelvic vessels. Incidence of diffuse hemorrhage was 0.61% in a prospective study including 2116 surgical hysteroscopies (4). Hemorrhage was subjectively defined by the surgeon as a procedure requiring red blood cell transfusion or hemostatic intervention. Risk of bleeding was associated with the type of procedure and was five times higher in cases of adhesiolysis than resection of the endometrium, polyps or fibroids. There was no difference in risk of bleeding complications when comparing endometrial ablation, uterine septum division, polyp and fibroid resection. However, rates of bleeding do vary between studies, as other groups have found incidence rates of 0-0.16% (1) (2) (3) . Swift identification of bleeding and its possible cause is crucial. Management options include intracavitary placement of a Foley catheter with a 30-mL balloon providing counter-pressure, or more, depending on uterine size. In rare cases, the bleeding may require uterine arterial embolization or hysterectomy.
Uterine perforation is one of the most common complications of OH, with an incidence of 0.12-3% (1-3). Perforation can be partial or complete and will in the latter case cause inability to maintain cavitary distention, leading to termination of the procedure. Perforation caused by a blunt instrument during dilation of the cervix can be managed conservatively if major bleeding is not suspected. However, damage by electrosurgical electrodes may lead to more serious injuries (2) . One case of mors in tabula is known to the author G.H. (personal communication) due to perforation and injury of the aortic bifurcation with a monopolar electrode. In cases of significant changes of red blood cell count or suspected thermal bowel injury, explorative laparoscopy is warranted.
Importantly, uterine perforation is a potential cause of uterine rupture in pregnancy (5) .
The majority of the 19 perforations (0.76%) of 2515 OHs were entry-related, i.e. dilation caused by hysteroscope or dilating devices resulting in four cases of severe bleeding managed with hysterectomy, one laparotomy and two laparoscopies, respectively. The small bowel was perforated in one case, requiring a laparotomy to repair the lesion (2) . In contrast, a large multicenter survey including 21 676 OHs demonstrated that most of the perforations (17 of 25, 68%) that occurred during fibroid or polyp resection were not related to entry (1) . Seven of the 25 perforations led to laparotomies, including five hysterectomies. Concurrent bladder or bowel injury was observed in five of the seven perforations. Laparoscopies with coagulation and/or sutures were performed in seven cases. In 11 cases no further surgical treatment was warranted.
Cervical ripening may prevent the risk of uterine perforation and thus more severe complications such as hemorrhage. A randomized controlled trial evaluating the use of 200 lg of vaginal misoprostol before OH found a reduced need for cervical dilation, thus reducing operative time, with fewer trauma-related complications (6) . In postmenopausal women, an additional 14-day pretreatment with vaginal estradiol with 1000 lg of vaginal misoprostol has proved to be necessary to reach satisfactory cervical dilation (7) . In cases of suspected uterine perforation without hemodynamic instability and suspicion of damage to major vessels, postoperative monitoring of red blood cell count is essential and a single dose of prophylactic antibiotic may be considered.
Infection
Infection is a rare complication of OH. In a retrospective survey of 21 676 procedures the infection rate was 0.01% (1), rising to 1.42% in a prospective observational study of 2116 OHs consisting of endometritis (0.9%) and urinary tract infections (0.6%) (8) . Risk of infection was higher for adhesiolysis than endometrial resection, fibroma or polyp resection with a relative risk (RR) of 5-6. Prevention of infection may be possible by reducing operation time. Prophylactic antibiotics are not routinely recommended in OH (9).
Fluid overload -OHIA syndrome
The operative hysteroscopy intravascular absorption (OHIA) syndrome may occur due to excessive fluid overload caused by intravasation of distension media (10, 11) , leading to hyponatremia and volume overload (12) . It is caused by differences in venous pressure in myometrial vessels (10-15 mmHg) and intrauterine pressure for distention of the cavity (40-60 mmHg), causing rapid intravasation, hyponatremia and, in severe cases, metabolic acidosis, pulmonary and cerebral edema (11) . The amount of electrolyte disturbances is highly dependent on the type of distension media used, i.e. isotonic NaCl in the case of bipolar resectoscope or hypotonic solutions used with monopolar instruments. Using isotonic solutions, absorption of 1000-2000 mL occurs in 5-10% of patients with mild OHIA, whereas the classic syndrome develops in <1% with intravascular absorption in excess of more than 2000 mL, with severe OHIA being associated with a mortality of 25% (11) . Prevention of OHIA is feasible by continuous fluid monitoring. A threshold of fluid loss of about 1500-2500 mL should be observed when performing OH. These values are less applicable when using non-isotonic distension media. Thus, a recent guideline by the British Society of Gynaecological Endoscopy (BSGE) and the European Society of Gynaecological Endoscopy (ESGE) on fluid management in OH refers to an upper threshold for isotonic media of 2500 mL and for hyptonic fluids of 1000 mL in healthy women (13) . Lower thresholds should be applied in patients with comorbidities and advanced age with upper fluid deficit levels of 750 mL for hypotonic solutions and 1500 mL for isotonic solutions (13) . To minimize the risk of hyponatremia and its consequences, isotonic media and bipolar equipment are preferred.
Late complications and suboptimal outcome

Incomplete resection
Patients with acute menstrual bleeding, heavy menstrual bleeding or infertility issues and submucosal myomas can be treated successfully. The ESGE classification of submucosal myomas with type 0 (pedunculated submucous fibroid without intramural extension) and I (sessile and with an intramural part of <50%) are more successfully treated with OH compared with type II (an intramural part of 50% or more) (14) (15) (16) . The extent of myometrial penetration predicts whether submucosal resection is complete (17) . The incidence of incomplete resection rates range from 5 to 20.5% (12, 16, 18) . In a retrospective study of 235 women, 12 patients (5%) had incomplete resection and all had repeat procedures (12) . There were no synechiae at follow-up hysteroscopy at one to two months, although 70% of the myomas were type II lesions. Uterine size and number of submucosal myomas are prognostic factors for recurrence and need for repeat surgery (18) . A prospective observational study of 122 patients found that the RR for fibroid-related surgery within four years of follow up was significantly lower in women with fibroids measuring <3 cm in diameter with RR 0.21 compared with fibroids >3 cm in diameter, and the risk was lower among intracavitary lesions (types 0 and I) with RR 0.26 compared with intramural lesions (type II) (19) . Reoperations are usually performed, but may not always be necessary. In a follow-up study of incomplete hysteroscopic resection of 41 women with abnormal uterine bleeding, only 44% underwent further fibroid-related and symptom-associated surgery within three years (12) .
Classification of submucous myomas can predict and thus prevent incomplete resection. The STEP-W (size, topography, extension, penetration, wall) classification system (14) and the ESGE classification (15) have been validated and described for such purposes. The ESGE classification is a simpler classification that is easier to use in daily practice. However, the STEP-W has been shown to predict completeness of myoma resection with higher accuracy compared to the ESGE classification (17) .
Intrauterine adhesions
Intrauterine adhesions (IUA) may lead to recurrent pregnancy loss, infertility, hypermenorrhea and amenorrhea. The incidence of IUA after OH is unknown due to the small number of studies, with low patient numbers. There is no consensus on which classifications to use and the underlying pathologies are various. The adhesion rate following resection of uterine septa reached 6.7% (1 of 15) and appears to be higher in OHs for fibroids (20) . IUA rates after resection of more than one myoma, i.e. multiple myomas, were 45.5% (9 of 20) vs. single myomas 31.3% (10 of 32) (20) . Risk factors for IUA after hysteroscopic treatment of retained products of conception were analyzed in a retrospective cohort study (21) . Eighty-four women had a second-look hysteroscopy and the rate of IUA was 19%, 3.6% of which were severe. Acknowledgment of significantly increased risk of IUA in women undergoing OH for multiple fibroids and/or type III lesions is essential in the prevention of IUA. Therefore, risks and benefits of myoma surgery in patients with cavity-related subfertility issues should be weighed against the risk of IUA. In a prospective study, the incidence of IUA diagnosed by hysteroscopy after dilation and curettage has been found to be 16.3% (16 of 98 cases) (22) . Immediate and short-term complications have been found to be significantly lower in the group treated with misoprostol than with surgical treatment (23) . Problems presenting six months after discharge, problems such as menstruation, pain and infection were less common in the medically treated group. Surgical treatment carries a higher risk of perforation, damage to the endometrial lining and infection, which may lead to a higher incidence of IUA.
Despite a high risk of IUA recurrence after OH, the need for preventative measures remains controversial. A prospective randomized trial, comparing two patient groups with grade III synechiae, all of which had an intrauterine device inserted, received estrogen and progestin treatment for two months following OH (24) . Group 1 underwent a second adhesiolysis one week later. Group 2 did not undergo another procedure. There was no difference in spontaneous pregnancy rates or live birth rates. However, there was a significant difference between group 1 and 2 in terms of mild and severe adhesion formation at two months: 2.7% vs. 37% (p < 0.01) and 2.7% vs 14.2% (p < 0.05), respectively. Estrogen therapy is often used after adhesiolysis to prevent IUA; however, the evidence for this is poor and there are no randomized controlled trials. One trial with 60 women randomly assigned to estrogen and progestin treatment or no treatment following curettage for first trimester abortions found a significant increase in endometrial thickness (0.84 vs. 0.67 cm, p = 0.02) and volume (3.85 vs. 1.97 m 2 ) (25). The authors suggested that the findings may be significant in prevention of IUA.
Conclusion
Prevention of the most common complications is feasible with precautionary measures and awareness of risk factors. However, some complications such as IUA may be inevitable, due to lack of evidence-based preventative treatment options. Entry-related complications such as perforation and bleeding may be prevented by appropriate teaching of OH, identifying patients at high risk, cervical ripening with misoprostol in pre-menopausal women and with estradiol and misoprostol in post-menopausal women. Routine prophylactic antibiotics are not recommended. OHIA syndrome can be reduced, if not avoided, by close monitoring of fluid balance. In addition, presurgical classification of submucous myomas can identify patients at risk for prolonged operative time and/ or incomplete resection and thus reduce the risk of OHIA syndrome. OH retains a significant role in gynecological endoscopy.
Funding
No funding was received for this study.
